312 related articles for article (PubMed ID: 37082219)
1. New trends in diagnosing and treating ovarian cancer using nanotechnology.
Zhang J; Ding H; Zhang F; Xu Y; Liang W; Huang L
Front Bioeng Biotechnol; 2023; 11():1160985. PubMed ID: 37082219
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
Ding H; Zhang J; Zhang F; Xu Y; Liang W; Yu Y
Drug Deliv; 2022 Dec; 29(1):3218-3232. PubMed ID: 36259505
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology in ovarian cancer: Diagnosis and treatment.
Barani M; Bilal M; Sabir F; Rahdar A; Kyzas GZ
Life Sci; 2021 Feb; 266():118914. PubMed ID: 33340527
[TBL] [Abstract][Full Text] [Related]
5. Current Update on Nanotechnology-Based Approaches in Ovarian Cancer Therapy.
Bhardwaj BK; Thankachan S; Magesh P; Venkatesh T; Tsutsumi R; Suresh PS
Reprod Sci; 2023 Feb; 30(2):335-349. PubMed ID: 35585292
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis.
Kaur M; Nagpal M; Aggarwal G
Curr Drug Targets; 2023; 24(1):2-12. PubMed ID: 36200208
[TBL] [Abstract][Full Text] [Related]
8. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale.
Dreaden EC; El-Sayed MA
Acc Chem Res; 2012 Nov; 45(11):1854-65. PubMed ID: 22546051
[TBL] [Abstract][Full Text] [Related]
9. Potential nanotechnologies and molecular targets in the quest for efficient chemotherapy in ovarian cancer.
Rhoda K; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
Expert Opin Drug Deliv; 2015 Apr; 12(4):613-34. PubMed ID: 25300775
[TBL] [Abstract][Full Text] [Related]
10. Current trends and challenges in cancer management and therapy using designer nanomaterials.
Navya PN; Kaphle A; Srinivas SP; Bhargava SK; Rotello VM; Daima HK
Nano Converg; 2019 Jul; 6(1):23. PubMed ID: 31304563
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Lung Cancer Therapy Based on Nanomaterials: A Review.
Gholami L; Ivari JR; Nasab NK; Oskuee RK; Sathyapalan T; Sahebkar A
Curr Med Chem; 2023; 30(3):335-355. PubMed ID: 34375182
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple- Negative Breast Cancer (TNBC).
Kanugo A; Gautam RK; Kamal MA
Curr Pharm Biotechnol; 2022; 23(13):1581-1595. PubMed ID: 34967294
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine and versatile therapies for cancer treatment.
Shukla A; Maiti P
MedComm (2020); 2022 Sep; 3(3):e163. PubMed ID: 35992969
[TBL] [Abstract][Full Text] [Related]
15. General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.
Wakaskar RR
J Drug Target; 2018 Apr; 26(4):311-318. PubMed ID: 28797169
[TBL] [Abstract][Full Text] [Related]
16. Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics.
Engelberth SA; Hempel N; Bergkvist M
Crit Rev Oncog; 2014; 19(3-4):281-315. PubMed ID: 25271436
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicines: A Focus on Nanomaterials as Drug Delivery System with Current Trends and Future Advancement.
Pandey J; Dubey R; Kate A; Prasad B; Sinha A; Mishra MS
Drug Res (Stuttg); 2022 Sep; 72(7):355-366. PubMed ID: 35636435
[TBL] [Abstract][Full Text] [Related]
18. Telodendrimer-based nanocarriers for the treatment of ovarian cancer.
Xiao K; Suby N; Li Y; Lam KS
Ther Deliv; 2013 Oct; 4(10):1279-92. PubMed ID: 24116912
[TBL] [Abstract][Full Text] [Related]
19. Effective Cancer Management: Inimitable Role of Phytochemical Based Nano- Formulations.
Upaganlawar A; Polshettiwar S; Raut S; Tagalpallewar A; Pande V
Curr Drug Metab; 2022; 23(11):869-881. PubMed ID: 36065928
[TBL] [Abstract][Full Text] [Related]
20. Nanotherapeutics for the Treatment of Cancer and Arthritis.
Patel P; Meghani N; Kansara K; Kumar A
Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]